Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
In the SURPASS clinical trials, which evaluated tirzepatide in over 10,000 patients with type 2 diabetes, participants experienced average reductions in total cholesterol of approximately 5-10%, LDL-C reductions of 6-13%, and triglyceride reductions of 15-25%, depending on the dose administered
This study was sponsored by Pfizer Inc
Understanding that this side effect is a recognised consequence of the medication's mechanism of action can help patients and healthcare professionals implement appropriate preventative and management strategies
This antioxidant significantly contributes to neutralizing free radicals, which are caused by sun exposure, pollution, and lifestyle choices
Currently, approximately 40 million patients in the US have insurance coverage for Wegovy--30 million via commercial health insurance, and the remaining through Medicaid
